Last reviewed · How we verify
Menstrual blood stem cells — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Menstrual blood stem cells (Menstrual blood stem cells) — S-Evans Biosciences Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Menstrual blood stem cells TARGET | Menstrual blood stem cells | S-Evans Biosciences Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Menstrual blood stem cells CI watch — RSS
- Menstrual blood stem cells CI watch — Atom
- Menstrual blood stem cells CI watch — JSON
- Menstrual blood stem cells alone — RSS
Cite this brief
Drug Landscape (2026). Menstrual blood stem cells — Competitive Intelligence Brief. https://druglandscape.com/ci/menstrual-blood-stem-cells. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab